| 
December 26, 2011 Guideline Synthesis Guideline Summaries American College of Emergency Physicians American Medical Directors Association European Association of Urology Nurses European Federation of Neurological Societies Withdrawn Summaries These summaries have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that they are no longer current. See the Guideline Archive for a complete list of all guidelines that have been withdrawn from the NGC Web site. Please refer to NGC's FAQ page if you have additional questions about guidelines recently withdrawn. Centers for Disease Control and Prevention - A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults.
- A new product (VariZIGâ„¢) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol.
- Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States. A practical guide for physicians and other health-care and public health professionals.
- Influenza vaccination of health-care personnel. Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP).
- Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States.
- Management of multidrug-resistant organisms in healthcare settings, 2006.
- Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps.
- Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel.
- Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC.
- Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Recommendations to improve preconception health and health care - United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care.
- Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.
- Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.
European Federation of Neurological Societies - EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep.
European Society of Cardiology - Guidelines on the management of stable angina pectoris.
Infectious Diseases Society of America - The practice of travel medicine: guidelines by the Infectious Diseases Society of America.
IRSA - Stereotactic radiosurgery for patients with vestibular schwannomas.
Joint Council of Allergy, Asthma and Immunology - Food allergy: a practice parameter.
Kaiser Permanente Care Management Institute - Adult diabetes clinical practice guidelines.
- Depression clinical practice guidelines.
Announcements Annotated Bibliographies The Annotated Bibliographies database has been updated. Over 100 citations for recent guideline-related articles were added to this resource, most with links to PubMed and/or associated full text files. NGC Spotlight New research review, clinician and consumer guides added! Visit the AHRQ Evidence Reports page for a listing of reports produced under AHRQ's Evidence-based Practice Program and Effective Health Care Program. Conference News The Guidelines International Network (G-I-N) Conference 2012, will be held August 22-25, 2012 in Berlin, Germany. Submit abstracts until February 10, 2012. U.S. Food and Drug Administration (FDA) Advisories - December 20, 2011: Gilenya (fingolimod): The FDA has received a report of a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod). At this time, FDA cannot conclude whether the drug resulted in the patient's death, but will continue to evaluate the case and will communicate any new information that results from this investigation.
- December 19, 2011: Multaq (dronedarone): FDA completed a safety review of Multaq (dronedarone) that showed that Multaq increased the risk of serious cardiovascular events, including death, when used by patients in permanent atrial fibrillation (AF). FDA is providing new information and recommendations for the use of Multaq to manage the potential serious cardiovascular risks with the drug. The Multaq drug label has been revised.
- December 14, 2011: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: FDA notified healthcare professionals and the public on the use of selective serotonin reuptake inhibitor (SSRI) antidepressants by women during pregnancy and the potential risk of a rare heart and lung condition known as Persistent Pulmonary Hypertension of the Newborn (PPHN). There have been conflicting findings from new studies evaluating this potential risk, making it unclear whether use of SSRIs during pregnancy can cause PPHN. FDA has reviewed new study results and has concluded that it is premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN. FDA will update the SSRI drug labels to reflect the new data and the conflicting results.
NGC's Sister Resources
| This email was sent to guyperea@live.com using GovDelivery, on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 540 Gaither Road · Rockville, MD 20850 · 301-427-1364 |  | |
No comments:
Post a Comment